Use of the combined first-trimester screen result and low PAPP-A to predict risk of adverse fetal outcomes

被引:63
作者
Barrett, Sandie L.
Bower, Carol [1 ,2 ]
Hadlow, Narelle C.
机构
[1] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Nedlands, WA 6009, Australia
[2] King Edward Mem Hosp Women, Birth Defects Registry, Perth, WA, Australia
关键词
first-trimester screening; adverse pregnancy outcomes; PAPP-A; trisomy; 21;
D O I
10.1002/pd.1898
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objectives To investigate associations between combined first-trimester screen result, pregnancy associated plasma protein-A (PAPP-A) level and adverse fetal outcomes in women. Methods Pregnancy outcomes for 10 273 women participating in a community based first-trimester screening (FTS) programme in Western Australia were ascertained by record linkage to birth and birth defect databases. A first-trimester risk cut-olf of >= 1 in 300 defined screen positive women. Results Screen positive pregnancies were more likely to have Down syndrome and birth defects (chromosomal or nonchromosomal) than screen negative pregnancies. When birth defects were excluded, screen positive pregnancies were at increased risk of pregnancy loss, low birth weight and preterm birth. Pregnancies with low PAPP-A (<= 0.3 multiples of the median (MoM)) had higher risk of chromosomal abnormality, birth defect, preterm birth, low birth weight, or pregnancy loss, compared to those with PAPP-A >0.3 MoM. In pregnancies without birth defects, low PAPP-A was a stronger predictor of preterm birth, low birth weight or pregnancy loss than a screen positive result. Conclusions Women with positive screen or low PAPP-A were at increased risk for some adverse fetal outcomes. The sensitivity of these parameters was inSufficient to support primary screening, but increased surveillance during pregnancy may be appropriate. Copyright (c) 2008 John Wiley & Sons, Ltd.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 33 条
[1]   Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population [J].
Adekunle, O ;
Gopee, A ;
El-Sayed, M ;
Thilaganathan, B .
BRITISH JOURNAL OF RADIOLOGY, 1999, 72 (857) :457-460
[2]   Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies [J].
Avgidou, K ;
Papageorghiou, A ;
Bindra, R ;
Spencer, K ;
Nicolaides, KH .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 192 (06) :1761-1767
[3]  
Bower C, 2001, TERATOLOGY, V63, P23, DOI 10.1002/1096-9926(200101)63:1<23::AID-TERA1004>3.0.CO
[4]  
2-S
[5]   Ascertainment of birth defects: The effect on completeness of adding a new source of data [J].
Bower, C ;
Silva, D ;
Henderson, TR ;
Ryan, A ;
Rudy, E .
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2000, 36 (06) :574-576
[6]  
BOWER C, 1995, PERSPECT HUM BIOL, V1, P29
[7]   Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening [J].
Cheng, CC ;
Bahado-Singh, RO ;
Chen, SC ;
Tsai, MS .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2004, 84 (01) :5-9
[8]   First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial) [J].
Dugoff, L ;
Hobbins, JC ;
Malone, FD ;
Porter, TF ;
Luthy, D ;
Comstock, CH ;
Hankins, G ;
Berkowitz, RL ;
Merkatz, I ;
Craigo, SD ;
Timor-Tritsch, IE ;
Carr, SR ;
Wolfe, HM ;
Vidaver, J ;
D'Alton, ME .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (04) :1446-1451
[9]  
GEE V, 2002, PERINATAL STAT W AUS
[10]   Community-based screening for Down's Syndrome in the first trimester using ultrasound and maternal serum biochemistry [J].
Hadlow, NC ;
Hewitt, BG ;
Dickinson, JE ;
Jacoby, P ;
Bower, C .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2005, 112 (11) :1561-1564